Compare Grauer & Weil with Similar Stocks
Dashboard
Poor long term growth as Net Sales has grown by an annual rate of 12.78% and Operating profit at 9.14% over the last 5 years
Negative results in Jun 26
With ROE of 15.2, it has a Very Expensive valuation with a 2.9 Price to Book Value
Despite the size of the company, domestic mutual funds hold only 0.01% of the company
Below par performance in long term as well as near term
Stock DNA
Commodity Chemicals
INR 3,165 Cr (Small Cap)
20.00
44
0.72%
-0.41
15.16%
2.90
Total Returns (Price + Dividend) 
Latest dividend: 0.5 per share ex-dividend date: Aug-06-2025
Risk Adjusted Returns v/s 
Returns Beta
News
Are Grauer & Weil (India) Ltd latest results good or bad?
Grauer & Weil (India) Ltd reported its financial results for Q1 FY27, revealing a mixed operational performance. The company achieved a net sales figure of ₹298.68 crores, reflecting a year-on-year growth of 17.93%. However, this revenue growth did not translate into improved profitability, as the net profit for the quarter was ₹39.81 crores, which represents a decline of 8.71% compared to the same quarter last year and a more pronounced drop of 19.59% from the previous quarter. The operating margin saw a significant contraction, falling to 16.13% from 20.76% in the corresponding quarter last year, indicating challenges in cost management or pricing power. The profit after tax (PAT) margin also decreased to 13.33%, down from 17.22% year-on-year, highlighting systemic issues affecting profitability. The company experienced a sequential decline in both revenue and net profit, with revenue decreasing by 15.9...
Read full news article
Grauer & Weil (India) Ltd Valuation Shifts to Very Expensive Amid Market Pressure
Grauer & Weil (India) Ltd, a small-cap player in the commodity chemicals sector, has seen a marked shift in its valuation parameters, moving from expensive to very expensive territory. This change, coupled with a significant share price decline of 8.81% on 5 Aug 2026, raises questions about the stock’s price attractiveness relative to its historical averages and peer group benchmarks.
Read full news article
Grauer & Weil (India) Ltd Reports Negative Financial Trend Amid Margin Pressures
Grauer & Weil (India) Ltd, a small-cap player in the commodity chemicals sector, has reported a marked deterioration in its recent quarterly financial performance, signalling a shift from a previously stable trend to a negative trajectory. The company’s latest results for the quarter ended June 2026 reveal contraction in key profitability metrics and operational efficiency, raising concerns among investors and analysts alike.
Read full news article Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
06-Aug-2026 | Source : BSENewspaper publication of Unaudited Financial Result of Company for quarter ended 30th June 2026.
Board Meeting Outcome for Outcome Of Board Meeting
04-Aug-2026 | Source : BSEOutcome of Board Meeting held on 04th August 2026
Result - Financial Result For Quarter Ended 30Th June 2026
04-Aug-2026 | Source : BSEStandalone and Consolidated Financial Result for quarter ended 30th June 2026
Corporate Actions 
No Upcoming Board Meetings
Grauer & Weil (India) Ltd has declared 50% dividend, ex-date: 06 Aug 25
Grauer & Weil (India) Ltd has announced 1:10 stock split, ex-date: 11 Aug 11
Grauer & Weil (India) Ltd has announced 1:1 bonus issue, ex-date: 10 Apr 24
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 2 Schemes (0.0%)
Held by 14 FIIs (0.35%)
Poona Bottling Company Private Limited (18.92%)
Vijaya S (1.23%)
23.19%
Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY
YoY Growth in quarter ended Jun 2026 is 17.93% vs -4.10% in Jun 2025
YoY Growth in quarter ended Jun 2026 is -8.71% vs -14.00% in Jun 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 4.95% vs 15.09% in Sep 2024
Growth in half year ended Sep 2025 is -6.95% vs 18.77% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 5.23% vs 7.86% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -12.88% vs 12.24% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 4.98% vs 6.06% in Mar 2025
YoY Growth in year ended Mar 2026 is 4.35% vs 7.45% in Mar 2025






